NT5E and neoplasm: reported that the combined therapy of CAR-T cells, anti-PD-1-antibody, and CD73 inhibitor can specifically eliminate chemo-resistant tumor stem cells and overcome SCLC-mediated T-cell inhibition in a humanized orthotopic SCLC mouse model (129).